These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 28691818)
21. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease. Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094 [TBL] [Abstract][Full Text] [Related]
22. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein. Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419 [TBL] [Abstract][Full Text] [Related]
23. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers. Drew SC Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154 [TBL] [Abstract][Full Text] [Related]
25. Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's disease. Dudzik CG; Walter ED; Millhauser GL Biochemistry; 2011 Mar; 50(11):1771-7. PubMed ID: 21319811 [TBL] [Abstract][Full Text] [Related]
26. The role of His-50 of α-synuclein in binding Cu(II): pH dependence, speciation, thermodynamics and structure. Valensin D; Camponeschi F; Luczkowski M; Baratto MC; Remelli M; Valensin G; Kozlowski H Metallomics; 2011 Mar; 3(3):292-302. PubMed ID: 21212878 [TBL] [Abstract][Full Text] [Related]
27. Bioinorganic chemistry of synucleinopathies: deciphering the binding features of Met motifs and His-50 in AS-Cu(I) interactions. Miotto MC; Binolfi A; Zweckstetter M; Griesinger C; Fernández CO J Inorg Biochem; 2014 Dec; 141():208-211. PubMed ID: 25218565 [TBL] [Abstract][Full Text] [Related]
28. Comparing the copper binding features of alpha and beta synucleins. Rodríguez EE; Ríos A; Trujano-Ortiz LG; Villegas A; Castañeda-Hernández G; Fernández CO; González FJ; Quintanar L J Inorg Biochem; 2022 Apr; 229():111715. PubMed ID: 35074552 [TBL] [Abstract][Full Text] [Related]
29. Coordination abilities of N-terminal fragments of alpha-synuclein towards copper(II) ions: a combined potentiometric and spectroscopic study. Kowalik-Jankowska T; Rajewska A; Wiśniewska K; Grzonka Z; Jezierska J J Inorg Biochem; 2005 Dec; 99(12):2282-91. PubMed ID: 16203037 [TBL] [Abstract][Full Text] [Related]
30. Copper ion incorporation in α-synuclein amyloids. Walke G; Kumar R; Wittung-Stafshede P Protein Sci; 2024 Apr; 33(4):e4956. PubMed ID: 38511511 [TBL] [Abstract][Full Text] [Related]
31. Effect of dioxygen on copper(II) binding to alpha-synuclein. Lucas HR; Lee JC J Inorg Biochem; 2010 Mar; 104(3):245-9. PubMed ID: 20064662 [TBL] [Abstract][Full Text] [Related]
32. Acetylation Rather than H50Q Mutation Impacts the Kinetics of Cu(II) Binding to α-Synuclein. Teng X; Sheveleva A; Tuna F; Willison KR; Ying L Chemphyschem; 2021 Dec; 22(23):2380. PubMed ID: 34779565 [TBL] [Abstract][Full Text] [Related]
33. NMR mapping of copper binding sites in alpha-synuclein. Sung YH; Rospigliosi C; Eliezer D Biochim Biophys Acta; 2006 Jan; 1764(1):5-12. PubMed ID: 16338184 [TBL] [Abstract][Full Text] [Related]
34. Interaction of Cu(i) with the Met-X Gentile I; Garro HA; Delgado Ocaña S; Gonzalez N; Strohäker T; Schibich D; Quintanar L; Sambrotta L; Zweckstetter M; Griesinger C; Menacho Márquez M; Fernández CO Metallomics; 2018 Oct; 10(10):1383-1389. PubMed ID: 30246210 [TBL] [Abstract][Full Text] [Related]
35. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation. Mason RJ; Paskins AR; Dalton CF; Smith DP Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125 [TBL] [Abstract][Full Text] [Related]
36. Cu(II) and dopamine bind to α-synuclein and cause large conformational changes. Tavassoly O; Nokhrin S; Dmitriev OY; Lee JS FEBS J; 2014 Jun; 281(12):2738-53. PubMed ID: 24725464 [TBL] [Abstract][Full Text] [Related]
37. Oxygen activation by the noncoupled binuclear copper site in peptidylglycine alpha-hydroxylating monooxygenase. Spectroscopic definition of the resting sites and the putative CuIIM-OOH intermediate. Chen P; Bell J; Eipper BA; Solomon EI Biochemistry; 2004 May; 43(19):5735-47. PubMed ID: 15134448 [TBL] [Abstract][Full Text] [Related]
38. Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease. Bharathi ; Rao KS Biochem Biophys Res Commun; 2007 Jul; 359(1):115-20. PubMed ID: 17531952 [TBL] [Abstract][Full Text] [Related]
39. Impact of N-terminal acetylation of α-synuclein on its random coil and lipid binding properties. Maltsev AS; Ying J; Bax A Biochemistry; 2012 Jun; 51(25):5004-13. PubMed ID: 22694188 [TBL] [Abstract][Full Text] [Related]
40. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study. Bharathi ; Indi SS; Rao KS Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]